SteadyMed Ltd. (STDY) to Release Earnings on Monday
SteadyMed Ltd. (NASDAQ:STDY) is scheduled to be releasing its earnings data before the market opens on Monday, August 14th. Analysts expect SteadyMed to post earnings of ($0.32) per share for the quarter.
SteadyMed Ltd. (STDY) opened at 6.25 on Monday. The company’s 50 day moving average is $6.49 and its 200-day moving average is $5.43. The firm’s market cap is $157.32 million. SteadyMed Ltd. has a 1-year low of $2.25 and a 1-year high of $9.70.
Separately, Zacks Investment Research lowered shares of SteadyMed from a “hold” rating to a “sell” rating in a research report on Tuesday, June 6th.
SteadyMed Ltd. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of various therapeutic product candidates. Its primary focus is to obtain approval in the United States for the sale of Trevyent for the treatment of pulmonary arterial hypertension (PAH).
Receive News & Ratings for SteadyMed Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SteadyMed Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.